New IVI Research Shows Challenges with ICER Budget Impact Forecasting

IVI research into six pre-2016 ICER studies reveals an overestimation of “unmanaged” drug use and drug cost trends. The peer-reviewed research, published in Value in Health, illustrates the difficulty in predicting budget impact and the consequences of not accounting for uncertainty in value assessment. Read the full article here.

2018-12-20T17:46:29-06:00December 20th, 2018|Publications, Research|

PRESS RELEASE: IVI’s Patient Research Reveals Importance of Quality of Life in Assessing Non-Small Cell Lung Cancer Therapy Sequence Value

Los Angeles, CA – November 15, 2018 – The Innovation and Value Initiative (IVI) – a nonprofit dedicated to advancing the science and improving the practice of value assessment in healthcare – today released qualitative research evaluating what factors most impact the value of treatment to metastatic non-small cell lung cancer patients. According to the [...]

2018-11-15T16:00:32-06:00November 15th, 2018|IVI News, Press, Research|

IVI Releases Non-Small Cell Lung Cancer Patient Qualitative Research

IVI has released the results to their non-small cell lung cancer patient qualitative research, which was used in the development of the structure of upcoming OSVP designed to evaluate lung cancer therapy sequences. According to the research, which was conducted in collaboration with LUNGevity, patients reported valuing treatments that would help increase overall or progression [...]

2018-11-15T16:01:39-06:00November 15th, 2018|IVI News, Research|

IVI Open-Source Value Project on Display at ISPOR Europe

IVI economists showcased the results of multiple research streams supporting open-source value modeling initiative at the leading European conference for health economics and outcomes research. Presentation topics included: Development of open-source software for conducting value assessments; Implementation of a new approach for using public feedback to guide ongoing, iterative improvement of open-source value models; and [...]

2018-11-16T17:02:52-06:00November 14th, 2018|IVI News, Research|

PRESS RELEASE: IVI Releases Public Feedback and Technical Expert Panel Recommendations for Open-Source Platform Model to Assess Outcomes and Value of Rheumatoid Arthritis Therapies

Priorities Emerged Which Will Shape Version 2.0 of IVI’s RA Model Los Angeles, CA – September 20, 2018 -- The Innovation and Value Initiative (IVI) today released public feedback and recommendations from its Technical Expert Panel (TEP), an objective third party comprised of five leaders in health economics, epidemiology, rheumatology, and patient communities, which the [...]

2018-09-20T09:03:25-06:00September 20th, 2018|IVI News, Press, Research|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model [...]

2018-05-03T16:32:26-06:00April 16th, 2018|IVI News, Research|

IVI Report Examines Imbalances in Health Care Effectiveness Analyses

A new Innovation and Value Initiative (IVI) report found that cost-effectiveness analyses (CEAs) are disproportionately conducted on pharmaceutical interventions compared to other health care treatments. Learn more about what causes this and the potential policy solutions to achieve better overall balance of CEAs across health care interventions. Read more about the project and results here.

2018-04-17T15:06:48-06:00February 21st, 2018|IVI News, Research|

IVI Releases Protocol for Report on Cost-Effectiveness Analysis in Health Care

IVI released the research protocol for its first project, which examines the quality of evidence and methods used in cost-effectiveness analysis (CEA) in healthcare. The research protocol is available here. This is the first research project in a series that will look at issues of relevance to policy, value assessment practices or methods, economic questions related [...]

2018-04-17T15:07:47-06:00June 14th, 2017|IVI News, Research|

Academic and Industry Leaders Launch Initiative to Study Value in Healthcare

Thought leaders from academia and the healthcare industry today announced the formal launch of the Innovation and Value Initiative (IVI). The goal of IVI is to advance the science of value measurement and technology assessment, develop innovative approaches to link value to pricing, and influence the policy debate to ensure that future spending on healthcare [...]

2018-06-15T11:49:51-06:00September 28th, 2016|Research|

IVI and Health Affairs Launch New Featured Topic Series on Health Affairs Blog

Health Affairs blog, in collaboration with IVI, today launched a new featured topic series titled “Drugs and Medical Innovation.” As Health Affairs blog editor Chris Fleming notes in an introductory post, the areas of drugs and medical innovation “have long been central in health care and health policy, and recent developments have heightened their importance even more. The [...]

2017-07-14T07:27:19-06:00September 15th, 2016|Research|